Advertisement mid banner S-Tech 1
ARM Innovation Hub
Advertisement: Mogrify mid banner
Mid banner advertisement: BDO
Advertisement: Excalibur Healthcare mid banner
Advertisement: RSM mid banner
Advertisement: CJBS mid banner
Advertisement: Simpsons Creative
Advertisement: Kao Data Centre mid banner
Advertisement: EBCam mid banner
Advertisement: Cambridge Network mid banner
Advertisement: HCR Hewitsons mid banner
Advertisement: partnersand mid banner
Barr Ellison Solicitors – commercial property
22 July, 2021 - 11:59 By Tony Quested

HealthTech Cluster wallows in Amazon

Dotmatics in Bishop’s Stortford and in Cambridge have joined the AWS for Health initiative from Amazon Web Services to drive fresh scientific innovation across a global platform.

Dotmatics is a scientific informatics software and services company driving the automation of laboratory data workflows for scientific discovery and innovation research.

Its support for AWS will improve laboratory efficiency and accelerate the pace of scientific innovation by facilitating more rapid data access, analysis and exchange between scientists around the world.

AWS for Health is an initiative featuring services and solutions from AWS and AWS Partners, built specifically for healthcare, biopharma, and genomics customers. 

The initiative makes it easier for health customers to select the right tools and partners for their highest-priority workloads across the health community. 

For customers looking to accelerate deployments with solution-specific support, AWS for Health also identifies dedicated AWS health industry specialists, AWS Professional Services teams, and leading AWS Partners in each solution area.

Today’s research projects are often carried out across collaborative networks of pharmaceutical, biotech, academic, and contract research organisations (CROs). 

Manual results sharing and work requests using email, file shares and reports not only delay the research cycle but also introduce potential errors in data transcription and interpretation, thus slowing innovation. 

Successful cross-team projects depend on real-time scientific data exchange for informed project decisions. Added to this, increased volumes and complexity of data from high throughput experimentation mean scientists must automate their workflows to ensure clean data is available to take advantage of advanced data analytics such as AI and Machine Learning.

Dotmatics' cloud-based software provides simple, unified, real-time access to all research data in its own and third-party databases, coupled with integrated, scientifically aware informatics solutions for small molecule and biologics discovery that expedite scientific workflows and enable automation of instrument data acquisition and data processing so that in-house or multi-organisational research teams become more efficient.

Powered by AWS, data security on the Dotmatics Platform benefits from the security, scale, and agility of the cloud. The Dotmatics Platform provides a single point of access to all science data and functions across multidisciplinary groups. 

The flexibility enables scientists, collaborators and partners to instantly interact with the same data via the cloud regardless of location and time zone, fulfilling the promise of real time research. 

Alastair Hill, co-founder and CIO of Dotmatics said: “Our cloud-based systems are designed to provide real-time access to all scientific project data coupled with powerful analytics and visualisation, for all team members, irrespective of location. 

“An accessible and secure data foundation is key to improving innovation through better-informed decision-making for scientists, aided by next generation AI and machine learning. 

“We are delighted to be part of the AWS for Health initiative which brings together the best in the industry, making it easy for healthcare, biopharma, and genomics customers to find, test, buy, and deploy software that runs on AWS.” is collaborating with AWS to help rapidly upskill pharmaceutical companies seeking to harness technology to engage with physicians and lower the costs of commercialising new treatments. 

With the commercial brain built by, life science companies have been able to connect vast amounts of data and make significant improvements in engaging and communicating with doctors with agility and scale.

The collaboration between and AWS enables companies to roll out solutions quickly, internationally and integrated within their existing infrastructure. CEO Loubna Bouarfa said that the company “has built the most sophisticated AI brain for life sciences, with a range of AI applications that are empowering pharmaceutical staff to shorten the time to impact across critical parts of the value chain – including Value Access and Pricing.”

Newsletter Subscription

Stay informed of the latest news and features